FDA approves Sanofi's drug for stage 3 type 1 diabetes in children
The U.S. Food and Drug Administration approved Sanofi's injection to slow the loss of the body's own insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes, the agency said on Friday.
(Reporting by Kunal Das in Bengaluru)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 12, 2026 at 2:18 PM.